SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : SAMe
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: redwood who wrote (2)7/6/1999 1:12:00 AM
From: freelyhovering  Read Replies (1) of 11
 
redwood--basically I agree with you philosophically, however on this one, there is some good solid research in Europe, though not quite the numbers that the FDA usually requires for "proof". One study reported in Newsweek was of a double blind placebo, disipramine and SAMe application and SAMe was as good as the disipramine and hugely better then placebo. In a study at UC Irvine Med School, SAMe was used to treat severe depressives and was effective in 62% of cases and disipramine only in 50% of cases. So there is more then the usual research on this one then done on other supplements. Myron
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News